Literature DB >> 7674817

The somatostatin receptor family.

Y C Patel1, M T Greenwood, R Panetta, L Demchyshyn, H Niznik, C B Srikant.   

Abstract

The diverse biological effects of somatostatin (SST) are mediated through a family of G protein coupled receptors of which 5 members have been recently identified by molecular cloning. This review focuses on the molecular biology, pharmacology, expression, and function of these receptors with particular emphasis on the human (h) homologs. hSSTRs are encoded by a family of 5 genes which map to separate chromosomes and which, with one exception, are intronless. SSTR2 gives rise to spliced variants, SSTR2A and 2B. hSSTR1-4 display weak selectivity for SST-14 binding whereas hSSTR5 is SST-28 selective. Based on structural similarity and reactivity for octapeptide and hexapeptide SST analogs, hSSTR2,3, and 5 belong to a similar SSTR subclass. hSSTR1 and 4 react poorly with these analogs and belong to a separate subclass. All 5 hSSTRs are functionally coupled to inhibition of adenylyl cyclase via pertussis toxin sensitive GTP binding proteins. Some of the subtypes are also coupled to tyrosine phosphatase (SSTR1,2), Ca2+ channels (SSTR2), Na+/H+ exchanger (SSTR1), PLA-2 (SSTR4), and MAP kinase (SSTR4). mRNA for SSTR1-5 is widely expressed in brain and peripheral organs and displays an overlapping but characteristic pattern that is subtype-selective, and tissue- and species-specific. Pituitary and islet tumors express several SSTR genes suggesting that multiple SSTR subtypes are coexpressed in the same cell. Structure-function studies indicate that the core residues in SST-14 ligand Phe6-Phe11 dock within a ligand binding pocket located in TMDs 3-7 which is lined by hydrophobic and charged amino acid residues.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7674817     DOI: 10.1016/0024-3205(95)02082-t

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  56 in total

1.  Tonic control of peripheral cutaneous nociceptors by somatostatin receptors.

Authors:  S M Carlton; J Du; S Zhou; R E Coggeshall
Journal:  J Neurosci       Date:  2001-06-01       Impact factor: 6.167

Review 2.  Somatostatin receptor PET ligands - the next generation for clinical practice.

Authors:  Elin Pauwels; Frederik Cleeren; Guy Bormans; Christophe M Deroose
Journal:  Am J Nucl Med Mol Imaging       Date:  2018-10-20

Review 3.  Receptor radionuclide therapy with 90Y-[DOTA]0-Tyr3-octreotide (90Y-DOTATOC) in neuroendocrine tumours.

Authors:  Lisa Bodei; Marta Cremonesi; Chiara Grana; Paola Rocca; Mirco Bartolomei; Marco Chinol; Giovanni Paganelli
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-05-19       Impact factor: 9.236

4.  Dissociation between tumor shrinkage and hormonal response during somatostatin analog treatment in an acromegalic patient: preferential expression of somatostatin receptor subtype 3.

Authors:  A P Casarini; E M Pinto; R S Jallad; R R Giorgi; D Giannella-Neto; M D Bronstein
Journal:  J Endocrinol Invest       Date:  2006-10       Impact factor: 4.256

5.  Activation of somatostatin receptor II expression by transcription factors MIBP1 and SEF-2 in the murine brain.

Authors:  U Dörflinger; A Pscherer; M Moser; P Rümmele; R Schüle; R Buettner
Journal:  Mol Cell Biol       Date:  1999-05       Impact factor: 4.272

6.  Relative expression of mRNA for the somatostatin receptors in the caudate putamen of C57BL/6J and 129P3/J mice: strain and heroin effects.

Authors:  Stefan D Schlussman; Jared Cassin; Orna Levran; Yong Zhang; Ann Ho; Mary Jeanne Kreek
Journal:  Brain Res       Date:  2010-05-15       Impact factor: 3.252

7.  Interrelationships between somatostatin sst2A receptors and somatostatin-containing axons in rat brain: evidence for regulation of cell surface receptors by endogenous somatostatin.

Authors:  P Dournaud; H Boudin; A Schonbrunn; G S Tannenbaum; A Beaudet
Journal:  J Neurosci       Date:  1998-02-01       Impact factor: 6.167

8.  Gut hormones. Yesterday, today, and tomorrow.

Authors:  S J Mulvihill
Journal:  Ann Surg       Date:  1997-02       Impact factor: 12.969

Review 9.  Molecular pharmacology of somatostatin receptor subtypes.

Authors:  Y C Patel
Journal:  J Endocrinol Invest       Date:  1997-06       Impact factor: 4.256

Review 10.  Paracrine signaling in islet function and survival.

Authors:  Sean M Hartig; Aaron R Cox
Journal:  J Mol Med (Berl)       Date:  2020-02-17       Impact factor: 4.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.